<DOC>
	<DOCNO>NCT00150410</DOCNO>
	<brief_summary>- Whether combination three therapy - metformin sulfonylurea plus Exubera , investigational drug , control diabetes least much triple combination therapy metformin sulfonylurea plus Avandia , Food Drug Administration ( FDA ) approve drug . - Whether combination two therapy - metformin plus Exubera control diabetes least much triple combination therapy metformin sulfonylurea plus Avandia .</brief_summary>
	<brief_title>Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes Currently treat stable dos drug precede two ( 2 ) month Type 1 Diabetes Smoking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>